SCHEMBL31690549

CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	15/20	0.61

▸	SCTR	P47872	1/20	0.61

▸	TFPI	P10646	1/20	0.59

▸	CALCR	P30988	4/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31690552	0.97	GLP1R (0.61)	GLP1RSCTRTFPI
SCHEMBL29556880	0.92	GLP1R (0.57)	GLP1RSCTRTFPI
SCHEMBL29658174	0.90	GLP1R (0.62)	GLP1RSCTRTFPI
SCHEMBL30865073	0.90	CALCR (0.53)	GLP1RSCTRTFPICALCR
SCHEMBL30498856	0.90	GLP1R (0.68)	GLP1RSCTR
SCHEMBL29965306	0.90	GLP1R (0.57)	GLP1RSCTRTFPICALCR
SCHEMBL30865076	0.90	CALCR (0.52)	GLP1RSCTRTFPICALCR
SCHEMBL30436351	0.90	GLP1R (0.60)	GLP1RSCTRTFPICALCR
SCHEMBL30432523	0.89	TFPI (0.59)	GLP1RSCTRTFPICALCR
SCHEMBL30184109	0.89	CALCR (0.52)	GLP1RSCTRTFPICALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4623900-A2	METHODS AND COMPOSITIONS FOR THE PREVENTION OF TYPE 1 DIABETES	Dr. Mary Morris & Associates, LLC (US)	2025-10-01	—	—	EP	disclosed